Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré
Main Authors: | Bonnet, Maryline, Roper, Cally, Félix, Martine, Coulibaly, Léonie, Kankolongo, Gabriel Mufuta, Guthmann, Jean Paul |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2007
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868032/ |
Similar Items
-
Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali
by: Maiga, Hamma, et al.
Published: (2015) -
Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran
by: Zakeri, Sedigheh, et al.
Published: (2007) -
Decreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania
by: Hetzel, Manuel W, et al.
Published: (2006) -
High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children
by: Mombo-Ngoma, Ghyslain, et al.
Published: (2011) -
Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania
by: Mbugi, Erasto V, et al.
Published: (2006)